APAC Microbiome Sequencing Services Market

APAC Microbiome Sequencing Services Market Size (2024 to 2029)

As per the research report, the Asia pacific microbiome sequencing services market size is valued at USD 191.79 Million in 2024. It is expected to grow at a CAGR of 24.92% to reach USD 583.43 Million by 2029.

Microbiome sequencing for early cancer detection drives the market forward in this region. Cancer is one of the most common causes of death in several people. Colorectal cancer is the most common gastrointestinal malignancy. Due to an increase in living standards, changes in dietary structure, and an increasingly aging population, there is an increase in the incidence of colorectal cancer in China, with 400,000 new cases of colorectal cancer and 285,000 deaths every year. Based on some research, gut microbes are involved in developing colorectal cancer, which results in non-invasive detection based on the gut microbiome. This microbiome sequencing is used to study and detect developed bacteria in the body, which drives the market forward in this region.

Technological advancements in next-generation sequencing (NGS) are fuelling the microbiome sequencing services market in the Asia-Pacific region. It provides an advanced understanding of the human microbiome by allowing for the discovery of microbes with the prediction of their function. Microbes play an essential role in human life. NGS is used for amplicon sequencing, shotgun sequencing, and microbiome research. The advancement of next-generation sequencing (NGS) technology made less investment in investigating the genes and genomes of single cells and communities of microbes.

Increasing use of human microbiome therapy boosts the market ahead. The human body has different bacteria, fungi, protozoa, and viruses. A group of all these microorganisms is referred to as the microbiome. For this reason, so many genome sequencing technologies are used to study the microbial community. Microbial action differs based on diet, medication, age, stress levels, and other environmental factors. The microbiome can also perform DNA sequencing techniques, including 16S rRNA sequencing and shotgun metagenomics. Microbes therapy reduces the side effects and increases the therapeutic result. Microbes are mainly used to improve their efficacy and safety. Human health is maintained in large part by the human gut microbiota.

Precision medicine increases preventative care for the individual by increasing results and reducing the side effects of therapy. The microbiome plays an essential role in manufacturing drugs and enhancing the development of precision medicine. A patient's microbiome can be easily determined through DNA sequencing, providing a patient-specific microbial community in a sample and improving treatment success. Fecal microbiota transplantation is a successful FDA-approved microbiome-based therapeutic (FMT). The disease-associated microbiome is replaced by an entire microbial community transferred from a healthy donor to a sick recipient.

However, the lengthy approval process, lack of skilled professionals, and government restrictions are the factors that drive the market forward.

This research report on the APAC Microbiome Sequencing Services Market has been segmented and sub-segmented into the following categories:

By Technology:

• Sequencing by Synthesis (SBS)
• Sequencing by Ligation (SBL)
• Pyrosequencing
• Sanger Sequencing
• Others

By Application:

• shotgun Sequencing
• Targeted Gene Sequencing
• RNA Sequencing
• Whole Genome Sequencing
• Others

By Research Type:

• Internal Research
• Outsourced Research

By Laboratory Type:

• Wet Lab
• Dry Lab

By End User:

• Pharmaceutical
• Biotechnology

By Country:

• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• Thailand
• Malaysia
• Vietnam
• Philippines
• Indonesia
• Singapore
• Rest of APAC

The Asia Pacific has the largest market share next to North America due to increased advanced next-generation sequencing and microbiome therapies. Indians are focused on sequencing services. Human Microbiome Initiative of select endogamous populations of India aims at carefully selected endogamous population groups with different dietary habits.

Due to the rising prevalence of diseases like obesity, diabetes, and cancer, all these diseases' occurrence is related to the microbiome. Therefore, China is the best area to study the relationship between the microbiome, disease, and urbanization.

Japanese also used this service in recent years. This is because the Japanese (JP) have different food habits than others, which results in more Research on gut microbiomes which drives the microbiome sequencing services in this area.

KEY MARKET PARTICIPANTS:

A few of the noteworthy companies in the APAC Microbiome sequencing services market profiled in the report are Metabiomics Corp., Microbiome Therapeutics LLC, Microbiome Insights Inc., Rancho Biosciences, Zymo Research Corp., Molzym GmbH & Co., Ubiome Inc., Diversigen Inc., Merieux Nutrisciences Corporation, and Molecular Research LP.